Accurate prediction of myopic progression and high myopia by machine learning

Abstract

Background: Myopia is a leading cause of visual impairment in Asia and worldwide. However, accurately predicting the progression of myopia and the high risk of myopia remains a challenge. This study aims to develop a predictive model for the development of myopia.

Methods: We first retrospectively gathered 612 530 medical records from five independent cohorts, encompassing 227 543 patients ranging from infants to young adults. Subsequently, we developed a multivariate linear regression algorithm model to predict the progression of myopia and the risk of high myopia.

Result: The model to predict the progression of myopia achieved an R2 value of 0.964 vs a mean absolute error (MAE) of 0.119D [95% confidence interval (CI): 0.119, 1.146] in the internal validation set. It demonstrated strong generalizability, maintaining consistent performance across external validation sets: R2 = 0.950 vs MAE = 0.119D (95% CI: 0.119, 1.136) in validation study 1, R2 = 0.950 vs MAE = 0.121D (95% CI: 0.121, 1.144) in validation study 2, and R2 = 0.806 vs MAE = −0.066D (95% CI: −0.066, 0.569) in the Shanghai Children Myopia Study. In the Beijing Children Eye Study, the model achieved an R2 of 0.749 vs a MAE of 0.178D (95% CI: 0.178, 1.557). The model to predict the risk of high myopia achieved an area under the curve (AUC) of 0.99 in the internal validation set and consistently high area under the curve values of 0.99, 0.99, 0.96 and 0.99 in the respective external validation sets.

Conclusion: Our study demonstrates accurate prediction of myopia progression and risk of high myopia providing valuable insights for tailoring strategies to personalize and optimize the clinical management of myopia in children.

Keywords

myopia / progression / machine learning / prevention / precision medicine

References

[1.] Holden BA, Fricke TR, Wilson DA et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016; 123:1036-42. https://doi.org/10.1016/j.ophtha.2016.01.006.

[2.] Dirani M, Chan YH, Gazzard G et al. Prevalence of refractive error in Singaporean Chinese children: The Strabismus, Amblyopia, and Refractive Error in Young Singaporean Children (STARS) Study. Invest Ophth Vis Sci. 2010; 51:1348-55. https://doi.org/10.1167/iovs.09-3587.

[3.] Pan CW, Ramamurthy D, Saw SM Worldwide prevalence and risk factors for myopia. Ophthal Physl Opt. 2012; 32:3-16. https://doi.org/10.1111/j.1475-1313.2011.00884.x.

[4.] He MG, Xiang F, Zeng YF et al. Effect of Time Spent Outdoors at School on the Development of Myopia Among Children in China A Randomized Clinical Trial. Jama-J Am Med Assoc. 2015; 314:1142-8. https://doi.org/10.1001/jama.2015.10803.

[5.] Jonas JB, Xu L, Wei WB et al. Myopia in China: a population-based cross-sectional, histological, and experimental study. Lancet. 2016;388:20. https://doi.org/10.1016/S0140-6736(16)31947-X.

[6.] Dolgin E The myopia boom. Nature. 2015; 519:276-8. https://doi.org/10.1038/519276a.

[7.] Pärssinen O, Lyyra A Myopia and myopic progression among schoolchildren: a three-year follow-up study. Invest Ophthalmol Vis Sci. 1993;34:2794-802.

[8.] Zheng YF, Pan CW, Chay J et al. The economic cost of myopia in adults aged over 40 years in Singapore. Invest Ophth Vis Sci. 2013; 54:7532-7. https://doi.org/10.1167/iovs.13-12795.

[9.] Agyekum S, Chan PP, Zhang Y et al. Cost-effectiveness analysis of myopia management: A systematic review. Front Public Health. 2023;11:1093836. https://doi.org/10.3389/fpubh.2023.1093836.

[10.] Ma Y, Wen Y, Zhong H et al. Healthcare utilization and economic burden of myopia in urban China: A nationwide cost-of-illness study. J Glob Health. 2022;12:11003. https://doi.org/10.7189/jogh.12.11003.

[11.] Smith TS, Frick KD, Holden BA et al. Potential lost productivity resulting from the global burden of uncorrected refractive error. Bull World Health Organ. 2009; 87:431-7. https://doi.org/10.2471/BLT.08.055673.

[12.] Ramrattan RS, Wolfs RC, Panda-Jonas S et al. Prevalence and causes of visual field loss in the elderly and associations with impairment in daily functioning: the Rotterdam Study. Arch Ophthalmol. 2001; 119:1788-94. https://doi.org/10.1001/archopht.119.12.1788.

[13.] McCarty CA, Nanjan MB, Taylor HR Vision impairment predicts 5 year mortality. Brit J Ophthalmol. 2001; 85:322-6. https://doi.org/10.1136/bjo.85.3.322.

[14.] Taylor HR, Katala S, Munoz B et al. Increase in mortality associated with blindness in rural Africa. B World Health Organ. 1991;69:335-8.

[15.] Ikuno Y Overview of the complications of high myopia. Retina-J Ret Vit Dis. 2017;37:2347-51.

[16.] Algvere PV, Jahnberg P, Textorius O The Swedish retinal detachment register I.A database for epidemiological and clinical studies. Graef Arch Clin Exp. 1999; 237:137-44. https://doi.org/10.1007/s004170050208.

[17.] Lin HT, Long EP, Ding XH et al. Prediction of myopia development among Chinese school-aged children using refraction data from electronic medical records: A retrospective, multicentre machine learning study. Plos Med. 2018; 15:e1002674 https://doi.org/10.1371/journal.pmed.1002674.

[18.] Xiong R, Zhu Z, Jiang Y et al. Longitudinal changes and predictive value of choroidal thickness for myopia control after repeated low-level red-light therapy. Ophthalmology. 2023; 130:286-96. https://doi.org/10.1016/j.ophtha.2022.10.002.

[19.] Wu PC, Chuang MN, Choi J et al. Update in myopia and treatment strategy of atropine use in myopia control. Eye. 2019; 33:3-13. https://doi.org/10.1038/s41433-018-0139-7.